nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—ABCB1—Mitomycin—urinary bladder cancer	0.0793	0.183	CbGbCtD
Amiodarone—CYP2A6—Fluorouracil—urinary bladder cancer	0.0585	0.135	CbGbCtD
Amiodarone—CYP3A4—Thiotepa—urinary bladder cancer	0.036	0.0829	CbGbCtD
Amiodarone—CYP2C8—Fluorouracil—urinary bladder cancer	0.0288	0.0664	CbGbCtD
Amiodarone—CYP3A5—Etoposide—urinary bladder cancer	0.025	0.0576	CbGbCtD
Amiodarone—CYP2C8—Etoposide—urinary bladder cancer	0.0241	0.0554	CbGbCtD
Amiodarone—ABCB1—Gemcitabine—urinary bladder cancer	0.0228	0.0525	CbGbCtD
Amiodarone—CYP1A2—Fluorouracil—urinary bladder cancer	0.0223	0.0514	CbGbCtD
Amiodarone—CYP2C9—Fluorouracil—urinary bladder cancer	0.0201	0.0463	CbGbCtD
Amiodarone—CYP1A2—Etoposide—urinary bladder cancer	0.0186	0.0429	CbGbCtD
Amiodarone—CYP2C9—Cisplatin—urinary bladder cancer	0.0171	0.0393	CbGbCtD
Amiodarone—ABCB1—Cisplatin—urinary bladder cancer	0.0166	0.0382	CbGbCtD
Amiodarone—ABCB1—Etoposide—urinary bladder cancer	0.0163	0.0375	CbGbCtD
Amiodarone—ABCB1—Doxorubicin—urinary bladder cancer	0.0111	0.0256	CbGbCtD
Amiodarone—ABCB1—Methotrexate—urinary bladder cancer	0.0108	0.0248	CbGbCtD
Amiodarone—CYP2D6—Doxorubicin—urinary bladder cancer	0.0105	0.0241	CbGbCtD
Amiodarone—CYP3A4—Etoposide—urinary bladder cancer	0.00976	0.0225	CbGbCtD
Amiodarone—CYP3A4—Doxorubicin—urinary bladder cancer	0.00666	0.0153	CbGbCtD
Amiodarone—CYP2C19—urine—urinary bladder cancer	0.00458	0.0444	CbGeAlD
Amiodarone—THRA—prostate gland—urinary bladder cancer	0.00431	0.0418	CbGeAlD
Amiodarone—THRB—prostate gland—urinary bladder cancer	0.00431	0.0418	CbGeAlD
Amiodarone—EBP—female reproductive system—urinary bladder cancer	0.00399	0.0387	CbGeAlD
Amiodarone—CYP1A2—urine—urinary bladder cancer	0.00374	0.0363	CbGeAlD
Amiodarone—CYP2C9—urine—urinary bladder cancer	0.00355	0.0344	CbGeAlD
Amiodarone—CACNA1H—prostate gland—urinary bladder cancer	0.00346	0.0335	CbGeAlD
Amiodarone—THRB—renal system—urinary bladder cancer	0.00294	0.0285	CbGeAlD
Amiodarone—THRA—renal system—urinary bladder cancer	0.00294	0.0285	CbGeAlD
Amiodarone—CACNA1H—seminal vesicle—urinary bladder cancer	0.00292	0.0283	CbGeAlD
Amiodarone—CYP3A4—urine—urinary bladder cancer	0.00271	0.0263	CbGeAlD
Amiodarone—CYP2D6—urine—urinary bladder cancer	0.00267	0.0258	CbGeAlD
Amiodarone—CYP2A6—prostate gland—urinary bladder cancer	0.00256	0.0248	CbGeAlD
Amiodarone—CACNA1H—smooth muscle tissue—urinary bladder cancer	0.00245	0.0237	CbGeAlD
Amiodarone—THRB—female reproductive system—urinary bladder cancer	0.00235	0.0228	CbGeAlD
Amiodarone—THRA—female reproductive system—urinary bladder cancer	0.00235	0.0228	CbGeAlD
Amiodarone—CYP2A6—seminal vesicle—urinary bladder cancer	0.00216	0.021	CbGeAlD
Amiodarone—THRB—vagina—urinary bladder cancer	0.00213	0.0206	CbGeAlD
Amiodarone—CACNA2D2—vagina—urinary bladder cancer	0.0021	0.0204	CbGeAlD
Amiodarone—ADRB1—prostate gland—urinary bladder cancer	0.00206	0.0199	CbGeAlD
Amiodarone—SIGMAR1—prostate gland—urinary bladder cancer	0.00197	0.0191	CbGeAlD
Amiodarone—CACNA1H—female reproductive system—urinary bladder cancer	0.00189	0.0183	CbGeAlD
Amiodarone—EBP—Azacitidine—Gemcitabine—urinary bladder cancer	0.0018	1	CbGdCrCtD
Amiodarone—SIGMAR1—seminal vesicle—urinary bladder cancer	0.00167	0.0162	CbGeAlD
Amiodarone—KCNH2—prostate gland—urinary bladder cancer	0.00157	0.0152	CbGeAlD
Amiodarone—SIGMAR1—smooth muscle tissue—urinary bladder cancer	0.0014	0.0135	CbGeAlD
Amiodarone—THRA—lymph node—urinary bladder cancer	0.00138	0.0133	CbGeAlD
Amiodarone—THRB—lymph node—urinary bladder cancer	0.00138	0.0133	CbGeAlD
Amiodarone—CACNA2D2—lymph node—urinary bladder cancer	0.00136	0.0132	CbGeAlD
Amiodarone—KCNH2—seminal vesicle—urinary bladder cancer	0.00133	0.0129	CbGeAlD
Amiodarone—SIGMAR1—urethra—urinary bladder cancer	0.00132	0.0128	CbGeAlD
Amiodarone—CYP3A5—prostate gland—urinary bladder cancer	0.0013	0.0126	CbGeAlD
Amiodarone—CYP2A6—vagina—urinary bladder cancer	0.00126	0.0122	CbGeAlD
Amiodarone—ADRB1—female reproductive system—urinary bladder cancer	0.00112	0.0109	CbGeAlD
Amiodarone—CACNA1H—lymph node—urinary bladder cancer	0.0011	0.0107	CbGeAlD
Amiodarone—KCNH2—renal system—urinary bladder cancer	0.00107	0.0104	CbGeAlD
Amiodarone—KCNH2—urethra—urinary bladder cancer	0.00105	0.0102	CbGeAlD
Amiodarone—CYP2C8—renal system—urinary bladder cancer	0.000979	0.00949	CbGeAlD
Amiodarone—CYP1A1—epithelium—urinary bladder cancer	0.000974	0.00944	CbGeAlD
Amiodarone—SIGMAR1—vagina—urinary bladder cancer	0.000973	0.00944	CbGeAlD
Amiodarone—CYP1A2—renal system—urinary bladder cancer	0.000916	0.00888	CbGeAlD
Amiodarone—CYP1A1—renal system—urinary bladder cancer	0.000903	0.00876	CbGeAlD
Amiodarone—CYP1A1—urethra—urinary bladder cancer	0.000887	0.0086	CbGeAlD
Amiodarone—CYP3A5—renal system—urinary bladder cancer	0.000883	0.00856	CbGeAlD
Amiodarone—KCNH2—female reproductive system—urinary bladder cancer	0.000857	0.0083	CbGeAlD
Amiodarone—CYP2C19—vagina—urinary bladder cancer	0.000812	0.00787	CbGeAlD
Amiodarone—CYP2C8—female reproductive system—urinary bladder cancer	0.000784	0.0076	CbGeAlD
Amiodarone—KCNH2—vagina—urinary bladder cancer	0.000775	0.00751	CbGeAlD
Amiodarone—CYP1A1—female reproductive system—urinary bladder cancer	0.000723	0.00701	CbGeAlD
Amiodarone—CYP2C8—vagina—urinary bladder cancer	0.000709	0.00687	CbGeAlD
Amiodarone—CYP2C9—female reproductive system—urinary bladder cancer	0.000696	0.00675	CbGeAlD
Amiodarone—ABCB1—prostate gland—urinary bladder cancer	0.000688	0.00667	CbGeAlD
Amiodarone—CYP3A4—renal system—urinary bladder cancer	0.000663	0.00643	CbGeAlD
Amiodarone—CYP1A1—vagina—urinary bladder cancer	0.000654	0.00634	CbGeAlD
Amiodarone—CYP2D6—renal system—urinary bladder cancer	0.000652	0.00632	CbGeAlD
Amiodarone—CYP3A5—vagina—urinary bladder cancer	0.00064	0.0062	CbGeAlD
Amiodarone—SIGMAR1—lymph node—urinary bladder cancer	0.00063	0.0061	CbGeAlD
Amiodarone—ABCB1—seminal vesicle—urinary bladder cancer	0.000582	0.00564	CbGeAlD
Amiodarone—CYP3A4—female reproductive system—urinary bladder cancer	0.000531	0.00515	CbGeAlD
Amiodarone—CYP2D6—female reproductive system—urinary bladder cancer	0.000522	0.00506	CbGeAlD
Amiodarone—ABCB1—epithelium—urinary bladder cancer	0.000506	0.0049	CbGeAlD
Amiodarone—KCNH2—lymph node—urinary bladder cancer	0.000501	0.00486	CbGeAlD
Amiodarone—ABCB1—renal system—urinary bladder cancer	0.000469	0.00455	CbGeAlD
Amiodarone—ABCB1—urethra—urinary bladder cancer	0.000461	0.00447	CbGeAlD
Amiodarone—CYP1A1—lymph node—urinary bladder cancer	0.000423	0.0041	CbGeAlD
Amiodarone—ABCB1—female reproductive system—urinary bladder cancer	0.000376	0.00364	CbGeAlD
Amiodarone—ABCB1—vagina—urinary bladder cancer	0.00034	0.00329	CbGeAlD
Amiodarone—ABCB1—lymph node—urinary bladder cancer	0.00022	0.00213	CbGeAlD
Amiodarone—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00018	0.000586	CcSEcCtD
Amiodarone—Pneumonia—Methotrexate—urinary bladder cancer	0.00018	0.000584	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000179	0.000582	CcSEcCtD
Amiodarone—Pancytopenia—Epirubicin—urinary bladder cancer	0.000178	0.000578	CcSEcCtD
Amiodarone—Hypotension—Etoposide—urinary bladder cancer	0.000178	0.000577	CcSEcCtD
Amiodarone—Pain—Cisplatin—urinary bladder cancer	0.000177	0.000577	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000177	0.000575	CcSEcCtD
Amiodarone—Muscular weakness—Doxorubicin—urinary bladder cancer	0.000177	0.000575	CcSEcCtD
Amiodarone—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000177	0.000575	CcSEcCtD
Amiodarone—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000176	0.000572	CcSEcCtD
Amiodarone—Renal failure—Methotrexate—urinary bladder cancer	0.000176	0.00057	CcSEcCtD
Amiodarone—Neutropenia—Epirubicin—urinary bladder cancer	0.000175	0.00057	CcSEcCtD
Amiodarone—Dizziness—Thiotepa—urinary bladder cancer	0.000175	0.000569	CcSEcCtD
Amiodarone—Urticaria—Fluorouracil—urinary bladder cancer	0.000174	0.000565	CcSEcCtD
Amiodarone—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000173	0.000562	CcSEcCtD
Amiodarone—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000172	0.000558	CcSEcCtD
Amiodarone—Sweating—Methotrexate—urinary bladder cancer	0.000171	0.000556	CcSEcCtD
Amiodarone—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000171	0.000556	CcSEcCtD
Amiodarone—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000171	0.000556	CcSEcCtD
Amiodarone—Paraesthesia—Etoposide—urinary bladder cancer	0.000171	0.000555	CcSEcCtD
Amiodarone—Weight increased—Epirubicin—urinary bladder cancer	0.000171	0.000554	CcSEcCtD
Amiodarone—Pancreatitis—Doxorubicin—urinary bladder cancer	0.00017	0.000553	CcSEcCtD
Amiodarone—Weight decreased—Epirubicin—urinary bladder cancer	0.00017	0.000551	CcSEcCtD
Amiodarone—Dyspnoea—Etoposide—urinary bladder cancer	0.00017	0.000551	CcSEcCtD
Amiodarone—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000169	0.000549	CcSEcCtD
Amiodarone—Vomiting—Thiotepa—urinary bladder cancer	0.000168	0.000547	CcSEcCtD
Amiodarone—Pneumonia—Epirubicin—urinary bladder cancer	0.000168	0.000546	CcSEcCtD
Amiodarone—Rash—Thiotepa—urinary bladder cancer	0.000167	0.000542	CcSEcCtD
Amiodarone—Dermatitis—Thiotepa—urinary bladder cancer	0.000167	0.000542	CcSEcCtD
Amiodarone—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000167	0.000542	CcSEcCtD
Amiodarone—Headache—Thiotepa—urinary bladder cancer	0.000166	0.000539	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000166	0.000538	CcSEcCtD
Amiodarone—Decreased appetite—Etoposide—urinary bladder cancer	0.000165	0.000537	CcSEcCtD
Amiodarone—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000165	0.000535	CcSEcCtD
Amiodarone—Renal failure—Epirubicin—urinary bladder cancer	0.000164	0.000534	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000164	0.000533	CcSEcCtD
Amiodarone—Body temperature increased—Cisplatin—urinary bladder cancer	0.000164	0.000533	CcSEcCtD
Amiodarone—Fatigue—Etoposide—urinary bladder cancer	0.000164	0.000533	CcSEcCtD
Amiodarone—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000164	0.000532	CcSEcCtD
Amiodarone—Jaundice—Epirubicin—urinary bladder cancer	0.000163	0.000529	CcSEcCtD
Amiodarone—Pain—Etoposide—urinary bladder cancer	0.000163	0.000528	CcSEcCtD
Amiodarone—Constipation—Etoposide—urinary bladder cancer	0.000163	0.000528	CcSEcCtD
Amiodarone—Neutropenia—Doxorubicin—urinary bladder cancer	0.000162	0.000527	CcSEcCtD
Amiodarone—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000161	0.000524	CcSEcCtD
Amiodarone—Hepatitis—Methotrexate—urinary bladder cancer	0.00016	0.000521	CcSEcCtD
Amiodarone—Sweating—Epirubicin—urinary bladder cancer	0.00016	0.000521	CcSEcCtD
Amiodarone—Asthenia—Gemcitabine—urinary bladder cancer	0.00016	0.000519	CcSEcCtD
Amiodarone—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000158	0.000514	CcSEcCtD
Amiodarone—Weight increased—Doxorubicin—urinary bladder cancer	0.000158	0.000513	CcSEcCtD
Amiodarone—Pruritus—Gemcitabine—urinary bladder cancer	0.000158	0.000512	CcSEcCtD
Amiodarone—Nausea—Thiotepa—urinary bladder cancer	0.000157	0.000511	CcSEcCtD
Amiodarone—Weight decreased—Doxorubicin—urinary bladder cancer	0.000157	0.00051	CcSEcCtD
Amiodarone—Feeling abnormal—Etoposide—urinary bladder cancer	0.000157	0.000509	CcSEcCtD
Amiodarone—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000156	0.000507	CcSEcCtD
Amiodarone—Pneumonia—Doxorubicin—urinary bladder cancer	0.000156	0.000505	CcSEcCtD
Amiodarone—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000155	0.000505	CcSEcCtD
Amiodarone—Pruritus—Fluorouracil—urinary bladder cancer	0.000155	0.000503	CcSEcCtD
Amiodarone—Visual impairment—Methotrexate—urinary bladder cancer	0.000154	0.000502	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000153	0.000498	CcSEcCtD
Amiodarone—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000153	0.000497	CcSEcCtD
Amiodarone—Bradycardia—Epirubicin—urinary bladder cancer	0.000153	0.000496	CcSEcCtD
Amiodarone—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000152	0.000495	CcSEcCtD
Amiodarone—Renal failure—Doxorubicin—urinary bladder cancer	0.000152	0.000494	CcSEcCtD
Amiodarone—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000152	0.000493	CcSEcCtD
Amiodarone—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000152	0.000493	CcSEcCtD
Amiodarone—Urticaria—Etoposide—urinary bladder cancer	0.000151	0.000491	CcSEcCtD
Amiodarone—Jaundice—Doxorubicin—urinary bladder cancer	0.000151	0.00049	CcSEcCtD
Amiodarone—Body temperature increased—Etoposide—urinary bladder cancer	0.00015	0.000488	CcSEcCtD
Amiodarone—Abdominal pain—Etoposide—urinary bladder cancer	0.00015	0.000488	CcSEcCtD
Amiodarone—Hepatitis—Epirubicin—urinary bladder cancer	0.00015	0.000488	CcSEcCtD
Amiodarone—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00015	0.000487	CcSEcCtD
Amiodarone—Tinnitus—Methotrexate—urinary bladder cancer	0.000149	0.000486	CcSEcCtD
Amiodarone—Asthenia—Cisplatin—urinary bladder cancer	0.000149	0.000484	CcSEcCtD
Amiodarone—Sweating—Doxorubicin—urinary bladder cancer	0.000148	0.000482	CcSEcCtD
Amiodarone—Dizziness—Fluorouracil—urinary bladder cancer	0.000145	0.000471	CcSEcCtD
Amiodarone—Visual impairment—Epirubicin—urinary bladder cancer	0.000145	0.00047	CcSEcCtD
Amiodarone—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000144	0.000469	CcSEcCtD
Amiodarone—Diarrhoea—Cisplatin—urinary bladder cancer	0.000142	0.000462	CcSEcCtD
Amiodarone—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000142	0.000461	CcSEcCtD
Amiodarone—Alopecia—Methotrexate—urinary bladder cancer	0.000142	0.00046	CcSEcCtD
Amiodarone—Vomiting—Gemcitabine—urinary bladder cancer	0.000142	0.00046	CcSEcCtD
Amiodarone—Bradycardia—Doxorubicin—urinary bladder cancer	0.000141	0.000459	CcSEcCtD
Amiodarone—Rash—Gemcitabine—urinary bladder cancer	0.00014	0.000456	CcSEcCtD
Amiodarone—Dermatitis—Gemcitabine—urinary bladder cancer	0.00014	0.000456	CcSEcCtD
Amiodarone—Hypersensitivity—Etoposide—urinary bladder cancer	0.00014	0.000455	CcSEcCtD
Amiodarone—Tinnitus—Epirubicin—urinary bladder cancer	0.00014	0.000455	CcSEcCtD
Amiodarone—Erythema—Methotrexate—urinary bladder cancer	0.00014	0.000454	CcSEcCtD
Amiodarone—Headache—Gemcitabine—urinary bladder cancer	0.000139	0.000453	CcSEcCtD
Amiodarone—Flushing—Epirubicin—urinary bladder cancer	0.000139	0.000452	CcSEcCtD
Amiodarone—Vomiting—Fluorouracil—urinary bladder cancer	0.000139	0.000452	CcSEcCtD
Amiodarone—Hepatitis—Doxorubicin—urinary bladder cancer	0.000139	0.000451	CcSEcCtD
Amiodarone—Rash—Fluorouracil—urinary bladder cancer	0.000138	0.000449	CcSEcCtD
Amiodarone—Dermatitis—Fluorouracil—urinary bladder cancer	0.000138	0.000448	CcSEcCtD
Amiodarone—Headache—Fluorouracil—urinary bladder cancer	0.000137	0.000446	CcSEcCtD
Amiodarone—Dysgeusia—Methotrexate—urinary bladder cancer	0.000137	0.000444	CcSEcCtD
Amiodarone—Asthenia—Etoposide—urinary bladder cancer	0.000136	0.000443	CcSEcCtD
Amiodarone—Back pain—Methotrexate—urinary bladder cancer	0.000135	0.000439	CcSEcCtD
Amiodarone—Pruritus—Etoposide—urinary bladder cancer	0.000135	0.000437	CcSEcCtD
Amiodarone—Arrhythmia—Epirubicin—urinary bladder cancer	0.000134	0.000436	CcSEcCtD
Amiodarone—Visual impairment—Doxorubicin—urinary bladder cancer	0.000134	0.000435	CcSEcCtD
Amiodarone—Alopecia—Epirubicin—urinary bladder cancer	0.000133	0.000431	CcSEcCtD
Amiodarone—Nausea—Gemcitabine—urinary bladder cancer	0.000132	0.00043	CcSEcCtD
Amiodarone—Vomiting—Cisplatin—urinary bladder cancer	0.000132	0.000429	CcSEcCtD
Amiodarone—Vision blurred—Methotrexate—urinary bladder cancer	0.000132	0.000427	CcSEcCtD
Amiodarone—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000131	0.000427	CcSEcCtD
Amiodarone—Rash—Cisplatin—urinary bladder cancer	0.000131	0.000425	CcSEcCtD
Amiodarone—Dermatitis—Cisplatin—urinary bladder cancer	0.000131	0.000425	CcSEcCtD
Amiodarone—Erythema—Epirubicin—urinary bladder cancer	0.000131	0.000424	CcSEcCtD
Amiodarone—Diarrhoea—Etoposide—urinary bladder cancer	0.00013	0.000423	CcSEcCtD
Amiodarone—Nausea—Fluorouracil—urinary bladder cancer	0.00013	0.000423	CcSEcCtD
Amiodarone—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000129	0.000421	CcSEcCtD
Amiodarone—Tinnitus—Doxorubicin—urinary bladder cancer	0.000129	0.000421	CcSEcCtD
Amiodarone—Flushing—Doxorubicin—urinary bladder cancer	0.000129	0.000419	CcSEcCtD
Amiodarone—Dysgeusia—Epirubicin—urinary bladder cancer	0.000128	0.000416	CcSEcCtD
Amiodarone—Back pain—Epirubicin—urinary bladder cancer	0.000126	0.000411	CcSEcCtD
Amiodarone—Malaise—Methotrexate—urinary bladder cancer	0.000126	0.000409	CcSEcCtD
Amiodarone—Dizziness—Etoposide—urinary bladder cancer	0.000126	0.000409	CcSEcCtD
Amiodarone—Vertigo—Methotrexate—urinary bladder cancer	0.000125	0.000407	CcSEcCtD
Amiodarone—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000124	0.000403	CcSEcCtD
Amiodarone—Nausea—Cisplatin—urinary bladder cancer	0.000123	0.000401	CcSEcCtD
Amiodarone—Vision blurred—Epirubicin—urinary bladder cancer	0.000123	0.0004	CcSEcCtD
Amiodarone—Alopecia—Doxorubicin—urinary bladder cancer	0.000123	0.000399	CcSEcCtD
Amiodarone—Cough—Methotrexate—urinary bladder cancer	0.000122	0.000396	CcSEcCtD
Amiodarone—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000121	0.000394	CcSEcCtD
Amiodarone—Vomiting—Etoposide—urinary bladder cancer	0.000121	0.000393	CcSEcCtD
Amiodarone—Erythema—Doxorubicin—urinary bladder cancer	0.000121	0.000393	CcSEcCtD
Amiodarone—Agitation—Epirubicin—urinary bladder cancer	0.00012	0.00039	CcSEcCtD
Amiodarone—Rash—Etoposide—urinary bladder cancer	0.00012	0.00039	CcSEcCtD
Amiodarone—Dermatitis—Etoposide—urinary bladder cancer	0.00012	0.000389	CcSEcCtD
Amiodarone—Headache—Etoposide—urinary bladder cancer	0.000119	0.000387	CcSEcCtD
Amiodarone—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000118	0.000385	CcSEcCtD
Amiodarone—Malaise—Epirubicin—urinary bladder cancer	0.000118	0.000383	CcSEcCtD
Amiodarone—Discomfort—Methotrexate—urinary bladder cancer	0.000117	0.000381	CcSEcCtD
Amiodarone—Vertigo—Epirubicin—urinary bladder cancer	0.000117	0.000381	CcSEcCtD
Amiodarone—Back pain—Doxorubicin—urinary bladder cancer	0.000117	0.00038	CcSEcCtD
Amiodarone—Confusional state—Methotrexate—urinary bladder cancer	0.000115	0.000373	CcSEcCtD
Amiodarone—Cough—Epirubicin—urinary bladder cancer	0.000114	0.00037	CcSEcCtD
Amiodarone—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000114	0.00037	CcSEcCtD
Amiodarone—Vision blurred—Doxorubicin—urinary bladder cancer	0.000114	0.00037	CcSEcCtD
Amiodarone—Infection—Methotrexate—urinary bladder cancer	0.000113	0.000368	CcSEcCtD
Amiodarone—Nausea—Etoposide—urinary bladder cancer	0.000113	0.000367	CcSEcCtD
Amiodarone—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000112	0.000364	CcSEcCtD
Amiodarone—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000112	0.000362	CcSEcCtD
Amiodarone—Agitation—Doxorubicin—urinary bladder cancer	0.000111	0.000361	CcSEcCtD
Amiodarone—Anxiety—Epirubicin—urinary bladder cancer	0.000111	0.00036	CcSEcCtD
Amiodarone—Skin disorder—Methotrexate—urinary bladder cancer	0.000111	0.00036	CcSEcCtD
Amiodarone—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00011	0.000358	CcSEcCtD
Amiodarone—Discomfort—Epirubicin—urinary bladder cancer	0.00011	0.000357	CcSEcCtD
Amiodarone—Malaise—Doxorubicin—urinary bladder cancer	0.000109	0.000354	CcSEcCtD
Amiodarone—Dry mouth—Epirubicin—urinary bladder cancer	0.000109	0.000353	CcSEcCtD
Amiodarone—Vertigo—Doxorubicin—urinary bladder cancer	0.000109	0.000353	CcSEcCtD
Amiodarone—Anorexia—Methotrexate—urinary bladder cancer	0.000109	0.000353	CcSEcCtD
Amiodarone—Confusional state—Epirubicin—urinary bladder cancer	0.000107	0.000349	CcSEcCtD
Amiodarone—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000107	0.000346	CcSEcCtD
Amiodarone—Oedema—Epirubicin—urinary bladder cancer	0.000107	0.000346	CcSEcCtD
Amiodarone—Hypotension—Methotrexate—urinary bladder cancer	0.000106	0.000346	CcSEcCtD
Amiodarone—Infection—Epirubicin—urinary bladder cancer	0.000106	0.000344	CcSEcCtD
Amiodarone—Cough—Doxorubicin—urinary bladder cancer	0.000105	0.000343	CcSEcCtD
Amiodarone—Shock—Epirubicin—urinary bladder cancer	0.000105	0.000341	CcSEcCtD
Amiodarone—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000104	0.000339	CcSEcCtD
Amiodarone—Tachycardia—Epirubicin—urinary bladder cancer	0.000104	0.000338	CcSEcCtD
Amiodarone—Skin disorder—Epirubicin—urinary bladder cancer	0.000104	0.000336	CcSEcCtD
Amiodarone—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000103	0.000335	CcSEcCtD
Amiodarone—Insomnia—Methotrexate—urinary bladder cancer	0.000103	0.000335	CcSEcCtD
Amiodarone—Anxiety—Doxorubicin—urinary bladder cancer	0.000103	0.000333	CcSEcCtD
Amiodarone—Paraesthesia—Methotrexate—urinary bladder cancer	0.000102	0.000332	CcSEcCtD
Amiodarone—Discomfort—Doxorubicin—urinary bladder cancer	0.000102	0.00033	CcSEcCtD
Amiodarone—Anorexia—Epirubicin—urinary bladder cancer	0.000102	0.00033	CcSEcCtD
Amiodarone—Dyspnoea—Methotrexate—urinary bladder cancer	0.000102	0.00033	CcSEcCtD
Amiodarone—Dry mouth—Doxorubicin—urinary bladder cancer	0.000101	0.000327	CcSEcCtD
Amiodarone—Dyspepsia—Methotrexate—urinary bladder cancer	0.0001	0.000326	CcSEcCtD
Amiodarone—Hypotension—Epirubicin—urinary bladder cancer	9.96e-05	0.000324	CcSEcCtD
Amiodarone—Confusional state—Doxorubicin—urinary bladder cancer	9.94e-05	0.000323	CcSEcCtD
Amiodarone—Decreased appetite—Methotrexate—urinary bladder cancer	9.9e-05	0.000322	CcSEcCtD
Amiodarone—Anaphylactic shock—Doxorubicin—urinary bladder cancer	9.86e-05	0.000321	CcSEcCtD
Amiodarone—Oedema—Doxorubicin—urinary bladder cancer	9.86e-05	0.000321	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	9.83e-05	0.00032	CcSEcCtD
Amiodarone—Fatigue—Methotrexate—urinary bladder cancer	9.82e-05	0.000319	CcSEcCtD
Amiodarone—Infection—Doxorubicin—urinary bladder cancer	9.8e-05	0.000318	CcSEcCtD
Amiodarone—Pain—Methotrexate—urinary bladder cancer	9.74e-05	0.000317	CcSEcCtD
Amiodarone—Shock—Doxorubicin—urinary bladder cancer	9.7e-05	0.000315	CcSEcCtD
Amiodarone—Thrombocytopenia—Doxorubicin—urinary bladder cancer	9.66e-05	0.000314	CcSEcCtD
Amiodarone—Insomnia—Epirubicin—urinary bladder cancer	9.64e-05	0.000313	CcSEcCtD
Amiodarone—Tachycardia—Doxorubicin—urinary bladder cancer	9.62e-05	0.000313	CcSEcCtD
Amiodarone—Skin disorder—Doxorubicin—urinary bladder cancer	9.58e-05	0.000311	CcSEcCtD
Amiodarone—Paraesthesia—Epirubicin—urinary bladder cancer	9.57e-05	0.000311	CcSEcCtD
Amiodarone—Hyperhidrosis—Doxorubicin—urinary bladder cancer	9.53e-05	0.00031	CcSEcCtD
Amiodarone—Dyspnoea—Epirubicin—urinary bladder cancer	9.5e-05	0.000309	CcSEcCtD
Amiodarone—Anorexia—Doxorubicin—urinary bladder cancer	9.4e-05	0.000306	CcSEcCtD
Amiodarone—Feeling abnormal—Methotrexate—urinary bladder cancer	9.38e-05	0.000305	CcSEcCtD
Amiodarone—Dyspepsia—Epirubicin—urinary bladder cancer	9.38e-05	0.000305	CcSEcCtD
Amiodarone—Gastrointestinal pain—Methotrexate—urinary bladder cancer	9.31e-05	0.000303	CcSEcCtD
Amiodarone—Decreased appetite—Epirubicin—urinary bladder cancer	9.26e-05	0.000301	CcSEcCtD
Amiodarone—Hypotension—Doxorubicin—urinary bladder cancer	9.21e-05	0.000299	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	9.2e-05	0.000299	CcSEcCtD
Amiodarone—Fatigue—Epirubicin—urinary bladder cancer	9.19e-05	0.000299	CcSEcCtD
Amiodarone—Pain—Epirubicin—urinary bladder cancer	9.11e-05	0.000296	CcSEcCtD
Amiodarone—Constipation—Epirubicin—urinary bladder cancer	9.11e-05	0.000296	CcSEcCtD
Amiodarone—Urticaria—Methotrexate—urinary bladder cancer	9.05e-05	0.000294	CcSEcCtD
Amiodarone—Body temperature increased—Methotrexate—urinary bladder cancer	9e-05	0.000293	CcSEcCtD
Amiodarone—Abdominal pain—Methotrexate—urinary bladder cancer	9e-05	0.000293	CcSEcCtD
Amiodarone—Insomnia—Doxorubicin—urinary bladder cancer	8.92e-05	0.00029	CcSEcCtD
Amiodarone—Paraesthesia—Doxorubicin—urinary bladder cancer	8.85e-05	0.000288	CcSEcCtD
Amiodarone—Dyspnoea—Doxorubicin—urinary bladder cancer	8.79e-05	0.000286	CcSEcCtD
Amiodarone—Feeling abnormal—Epirubicin—urinary bladder cancer	8.78e-05	0.000285	CcSEcCtD
Amiodarone—Gastrointestinal pain—Epirubicin—urinary bladder cancer	8.71e-05	0.000283	CcSEcCtD
Amiodarone—Dyspepsia—Doxorubicin—urinary bladder cancer	8.68e-05	0.000282	CcSEcCtD
Amiodarone—Decreased appetite—Doxorubicin—urinary bladder cancer	8.57e-05	0.000279	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	8.51e-05	0.000277	CcSEcCtD
Amiodarone—Fatigue—Doxorubicin—urinary bladder cancer	8.5e-05	0.000276	CcSEcCtD
Amiodarone—Urticaria—Epirubicin—urinary bladder cancer	8.47e-05	0.000275	CcSEcCtD
Amiodarone—Pain—Doxorubicin—urinary bladder cancer	8.43e-05	0.000274	CcSEcCtD
Amiodarone—Constipation—Doxorubicin—urinary bladder cancer	8.43e-05	0.000274	CcSEcCtD
Amiodarone—Body temperature increased—Epirubicin—urinary bladder cancer	8.43e-05	0.000274	CcSEcCtD
Amiodarone—Abdominal pain—Epirubicin—urinary bladder cancer	8.43e-05	0.000274	CcSEcCtD
Amiodarone—Hypersensitivity—Methotrexate—urinary bladder cancer	8.39e-05	0.000273	CcSEcCtD
Amiodarone—Asthenia—Methotrexate—urinary bladder cancer	8.17e-05	0.000266	CcSEcCtD
Amiodarone—Feeling abnormal—Doxorubicin—urinary bladder cancer	8.13e-05	0.000264	CcSEcCtD
Amiodarone—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	8.06e-05	0.000262	CcSEcCtD
Amiodarone—Pruritus—Methotrexate—urinary bladder cancer	8.06e-05	0.000262	CcSEcCtD
Amiodarone—Hypersensitivity—Epirubicin—urinary bladder cancer	7.85e-05	0.000255	CcSEcCtD
Amiodarone—Urticaria—Doxorubicin—urinary bladder cancer	7.83e-05	0.000255	CcSEcCtD
Amiodarone—Abdominal pain—Doxorubicin—urinary bladder cancer	7.8e-05	0.000253	CcSEcCtD
Amiodarone—Body temperature increased—Doxorubicin—urinary bladder cancer	7.8e-05	0.000253	CcSEcCtD
Amiodarone—Diarrhoea—Methotrexate—urinary bladder cancer	7.79e-05	0.000253	CcSEcCtD
Amiodarone—Asthenia—Epirubicin—urinary bladder cancer	7.65e-05	0.000249	CcSEcCtD
Amiodarone—Pruritus—Epirubicin—urinary bladder cancer	7.54e-05	0.000245	CcSEcCtD
Amiodarone—Dizziness—Methotrexate—urinary bladder cancer	7.53e-05	0.000245	CcSEcCtD
Amiodarone—Diarrhoea—Epirubicin—urinary bladder cancer	7.29e-05	0.000237	CcSEcCtD
Amiodarone—Hypersensitivity—Doxorubicin—urinary bladder cancer	7.27e-05	0.000236	CcSEcCtD
Amiodarone—Vomiting—Methotrexate—urinary bladder cancer	7.24e-05	0.000235	CcSEcCtD
Amiodarone—Rash—Methotrexate—urinary bladder cancer	7.18e-05	0.000233	CcSEcCtD
Amiodarone—Dermatitis—Methotrexate—urinary bladder cancer	7.17e-05	0.000233	CcSEcCtD
Amiodarone—Headache—Methotrexate—urinary bladder cancer	7.13e-05	0.000232	CcSEcCtD
Amiodarone—Asthenia—Doxorubicin—urinary bladder cancer	7.08e-05	0.00023	CcSEcCtD
Amiodarone—Dizziness—Epirubicin—urinary bladder cancer	7.05e-05	0.000229	CcSEcCtD
Amiodarone—Pruritus—Doxorubicin—urinary bladder cancer	6.98e-05	0.000227	CcSEcCtD
Amiodarone—Vomiting—Epirubicin—urinary bladder cancer	6.78e-05	0.00022	CcSEcCtD
Amiodarone—Nausea—Methotrexate—urinary bladder cancer	6.76e-05	0.00022	CcSEcCtD
Amiodarone—Diarrhoea—Doxorubicin—urinary bladder cancer	6.75e-05	0.000219	CcSEcCtD
Amiodarone—Rash—Epirubicin—urinary bladder cancer	6.72e-05	0.000218	CcSEcCtD
Amiodarone—Dermatitis—Epirubicin—urinary bladder cancer	6.71e-05	0.000218	CcSEcCtD
Amiodarone—Headache—Epirubicin—urinary bladder cancer	6.68e-05	0.000217	CcSEcCtD
Amiodarone—Dizziness—Doxorubicin—urinary bladder cancer	6.52e-05	0.000212	CcSEcCtD
Amiodarone—Nausea—Epirubicin—urinary bladder cancer	6.33e-05	0.000206	CcSEcCtD
Amiodarone—Vomiting—Doxorubicin—urinary bladder cancer	6.27e-05	0.000204	CcSEcCtD
Amiodarone—Rash—Doxorubicin—urinary bladder cancer	6.22e-05	0.000202	CcSEcCtD
Amiodarone—Dermatitis—Doxorubicin—urinary bladder cancer	6.21e-05	0.000202	CcSEcCtD
Amiodarone—Headache—Doxorubicin—urinary bladder cancer	6.18e-05	0.000201	CcSEcCtD
Amiodarone—Nausea—Doxorubicin—urinary bladder cancer	5.86e-05	0.00019	CcSEcCtD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.08e-05	0.000136	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—TYMP—urinary bladder cancer	2.07e-05	0.000136	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	2.06e-05	0.000135	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	2.06e-05	0.000135	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—NAT2—urinary bladder cancer	2.06e-05	0.000135	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.03e-05	0.000133	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.01e-05	0.000132	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—HPGDS—urinary bladder cancer	2.01e-05	0.000131	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ENO2—urinary bladder cancer	2.01e-05	0.000131	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—NAT2—urinary bladder cancer	2.01e-05	0.000131	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2e-05	0.000131	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.99e-05	0.00013	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—RRM2—urinary bladder cancer	1.99e-05	0.00013	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	1.98e-05	0.000129	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—GSTT1—urinary bladder cancer	1.95e-05	0.000127	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.92e-05	0.000126	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—NAT2—urinary bladder cancer	1.89e-05	0.000124	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—NAT2—urinary bladder cancer	1.88e-05	0.000123	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.86e-05	0.000122	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—RHOA—urinary bladder cancer	1.85e-05	0.000121	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ENO2—urinary bladder cancer	1.84e-05	0.000121	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	1.84e-05	0.000121	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—TYMS—urinary bladder cancer	1.84e-05	0.00012	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.83e-05	0.00012	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	1.82e-05	0.000119	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	1.82e-05	0.000119	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—GSTP1—urinary bladder cancer	1.81e-05	0.000119	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.79e-05	0.000117	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	1.79e-05	0.000117	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.78e-05	0.000116	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—RRM2—urinary bladder cancer	1.78e-05	0.000116	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—S100B—urinary bladder cancer	1.77e-05	0.000116	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—TYMP—urinary bladder cancer	1.77e-05	0.000116	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.76e-05	0.000115	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.76e-05	0.000115	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—GPX1—urinary bladder cancer	1.74e-05	0.000114	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.73e-05	0.000113	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—NQO1—urinary bladder cancer	1.71e-05	0.000112	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.71e-05	0.000112	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	1.71e-05	0.000112	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.7e-05	0.000111	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—TYMS—urinary bladder cancer	1.69e-05	0.00011	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—RHOA—urinary bladder cancer	1.68e-05	0.00011	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—NCOR1—urinary bladder cancer	1.67e-05	0.000109	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—GSTM1—urinary bladder cancer	1.67e-05	0.000109	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	1.64e-05	0.000108	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ENO2—urinary bladder cancer	1.64e-05	0.000108	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.63e-05	0.000107	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—RRM2—urinary bladder cancer	1.63e-05	0.000107	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.63e-05	0.000106	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—NQO1—urinary bladder cancer	1.62e-05	0.000106	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—RRM2—urinary bladder cancer	1.62e-05	0.000106	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	1.61e-05	0.000105	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.61e-05	0.000105	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.61e-05	0.000105	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—NAT2—urinary bladder cancer	1.6e-05	0.000105	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—GPX1—urinary bladder cancer	1.6e-05	0.000104	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	1.6e-05	0.000104	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—NCOR1—urinary bladder cancer	1.6e-05	0.000104	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.57e-05	0.000103	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.57e-05	0.000103	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—ERCC2—urinary bladder cancer	1.57e-05	0.000102	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.56e-05	0.000102	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—IL2—urinary bladder cancer	1.55e-05	0.000102	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ENO2—urinary bladder cancer	1.51e-05	9.89e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	1.51e-05	9.89e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ENO2—urinary bladder cancer	1.5e-05	9.81e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	1.5e-05	9.81e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.49e-05	9.75e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—NQO1—urinary bladder cancer	1.49e-05	9.71e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—CXCL8—urinary bladder cancer	1.48e-05	9.66e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—MTHFR—urinary bladder cancer	1.47e-05	9.63e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	1.47e-05	9.6e-05	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.46e-05	9.53e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	1.45e-05	9.51e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.44e-05	9.42e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.43e-05	9.37e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	1.43e-05	9.35e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—IL2—urinary bladder cancer	1.41e-05	9.23e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TERT—urinary bladder cancer	1.41e-05	9.19e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—RRM2—urinary bladder cancer	1.38e-05	9.05e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.37e-05	8.97e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.37e-05	8.95e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—GSTP1—urinary bladder cancer	1.35e-05	8.84e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—TYMS—urinary bladder cancer	1.33e-05	8.7e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—NQO1—urinary bladder cancer	1.33e-05	8.67e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	1.31e-05	8.6e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	1.31e-05	8.6e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.31e-05	8.55e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PPARG—urinary bladder cancer	1.3e-05	8.52e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.29e-05	8.46e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—FGFR3—urinary bladder cancer	1.29e-05	8.44e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.29e-05	8.41e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ENO2—urinary bladder cancer	1.28e-05	8.38e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	1.28e-05	8.38e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.27e-05	8.33e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—GPX1—urinary bladder cancer	1.26e-05	8.23e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.26e-05	8.22e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—TYMS—urinary bladder cancer	1.26e-05	8.22e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—ESR1—urinary bladder cancer	1.25e-05	8.2e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	1.25e-05	8.19e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	1.24e-05	8.13e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—NCOR1—urinary bladder cancer	1.24e-05	8.12e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—GSTM1—urinary bladder cancer	1.24e-05	8.12e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	1.24e-05	8.1e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.24e-05	8.09e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	1.24e-05	8.08e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.22e-05	8e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—NQO1—urinary bladder cancer	1.22e-05	7.97e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.21e-05	7.91e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.2e-05	7.84e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PPARG—urinary bladder cancer	1.19e-05	7.81e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—GPX1—urinary bladder cancer	1.19e-05	7.78e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.17e-05	7.67e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ERCC2—urinary bladder cancer	1.17e-05	7.64e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	1.16e-05	7.6e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—TYMS—urinary bladder cancer	1.15e-05	7.53e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—CREBBP—urinary bladder cancer	1.15e-05	7.5e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	1.14e-05	7.45e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	1.14e-05	7.45e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.12e-05	7.34e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.11e-05	7.23e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CREBBP—urinary bladder cancer	1.1e-05	7.18e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—MTHFR—urinary bladder cancer	1.1e-05	7.18e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GPX1—urinary bladder cancer	1.09e-05	7.13e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IGF1—urinary bladder cancer	1.08e-05	7.09e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.08e-05	7.06e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—EGFR—urinary bladder cancer	1.08e-05	7.06e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	1.07e-05	7e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.07e-05	7e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.07e-05	6.98e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—NQO1—urinary bladder cancer	1.03e-05	6.76e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.03e-05	6.72e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	1.02e-05	6.7e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.02e-05	6.69e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—KRAS—urinary bladder cancer	1.02e-05	6.67e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	1.02e-05	6.65e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.02e-05	6.65e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.02e-05	6.65e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.01e-05	6.59e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	1.01e-05	6.58e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—TYMS—urinary bladder cancer	1e-05	6.56e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1e-05	6.55e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—RHOA—urinary bladder cancer	9.93e-06	6.5e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—NCOR1—urinary bladder cancer	9.92e-06	6.49e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GSTM1—urinary bladder cancer	9.92e-06	6.49e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	9.89e-06	6.47e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ENO2—urinary bladder cancer	9.89e-06	6.47e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	9.75e-06	6.38e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GPX1—urinary bladder cancer	9.73e-06	6.36e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	9.59e-06	6.27e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	9.55e-06	6.25e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GPX1—urinary bladder cancer	9.5e-06	6.21e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—TYMS—urinary bladder cancer	9.45e-06	6.18e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PPARG—urinary bladder cancer	9.42e-06	6.16e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PTGS2—urinary bladder cancer	9.39e-06	6.14e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—TYMS—urinary bladder cancer	9.37e-06	6.13e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	9.34e-06	6.11e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	9.34e-06	6.11e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ERCC2—urinary bladder cancer	9.32e-06	6.1e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	9.26e-06	6.06e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	9.26e-06	6.06e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—ERBB2—urinary bladder cancer	9.2e-06	6.02e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	9.05e-06	5.92e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	8.98e-06	5.87e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GPX1—urinary bladder cancer	8.95e-06	5.85e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—PTEN—urinary bladder cancer	8.94e-06	5.85e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PPARG—urinary bladder cancer	8.9e-06	5.82e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GPX1—urinary bladder cancer	8.87e-06	5.8e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	8.79e-06	5.75e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—MTHFR—urinary bladder cancer	8.76e-06	5.73e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	8.74e-06	5.72e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CXCL8—urinary bladder cancer	8.72e-06	5.7e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	8.71e-06	5.7e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—HRAS—urinary bladder cancer	8.66e-06	5.67e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	8.61e-06	5.63e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CREBBP—urinary bladder cancer	8.55e-06	5.59e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—EP300—urinary bladder cancer	8.52e-06	5.58e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	8.33e-06	5.45e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL2—urinary bladder cancer	8.33e-06	5.45e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	8.26e-06	5.4e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—PTEN—urinary bladder cancer	8.19e-06	5.36e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	8.19e-06	5.36e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PPARG—urinary bladder cancer	8.16e-06	5.34e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CCND1—urinary bladder cancer	8.12e-06	5.31e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—TYMS—urinary bladder cancer	8.01e-06	5.24e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NQO1—urinary bladder cancer	7.97e-06	5.21e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	7.92e-06	5.18e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	7.92e-06	5.18e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MMP9—urinary bladder cancer	7.89e-06	5.16e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CDKN1A—urinary bladder cancer	7.86e-06	5.14e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PTEN—urinary bladder cancer	7.84e-06	5.13e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	7.84e-06	5.13e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—EP300—urinary bladder cancer	7.81e-06	5.11e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GPX1—urinary bladder cancer	7.58e-06	4.96e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—EP300—urinary bladder cancer	7.48e-06	4.89e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	7.44e-06	4.87e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	7.41e-06	4.85e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PPARG—urinary bladder cancer	7.28e-06	4.76e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SRC—urinary bladder cancer	7.27e-06	4.76e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PPARG—urinary bladder cancer	7.11e-06	4.65e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PTGS2—urinary bladder cancer	7e-06	4.58e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	7e-06	4.58e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	6.99e-06	4.58e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CREBBP—urinary bladder cancer	6.83e-06	4.47e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PPARG—urinary bladder cancer	6.7e-06	4.38e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	6.65e-06	4.35e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PPARG—urinary bladder cancer	6.64e-06	4.34e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MYC—urinary bladder cancer	6.52e-06	4.26e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—PTEN—urinary bladder cancer	6.46e-06	4.23e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	6.43e-06	4.21e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	6.42e-06	4.2e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	6.38e-06	4.17e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—EGFR—urinary bladder cancer	6.37e-06	4.17e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—TYMS—urinary bladder cancer	6.18e-06	4.04e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—EP300—urinary bladder cancer	6.16e-06	4.03e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	6.11e-06	4e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	6.11e-06	4e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—PTEN—urinary bladder cancer	6.1e-06	3.99e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—KRAS—urinary bladder cancer	6.02e-06	3.94e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GPX1—urinary bladder cancer	5.85e-06	3.83e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—EP300—urinary bladder cancer	5.82e-06	3.81e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	5.74e-06	3.76e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	5.73e-06	3.75e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PPARG—urinary bladder cancer	5.67e-06	3.71e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—PTEN—urinary bladder cancer	5.6e-06	3.66e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTGS2—urinary bladder cancer	5.59e-06	3.66e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	5.45e-06	3.56e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	5.4e-06	3.53e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TP53—urinary bladder cancer	5.35e-06	3.5e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—EP300—urinary bladder cancer	5.34e-06	3.49e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	5.27e-06	3.45e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	5.22e-06	3.42e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—HRAS—urinary bladder cancer	5.12e-06	3.35e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—PTEN—urinary bladder cancer	5e-06	3.27e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—PTEN—urinary bladder cancer	4.88e-06	3.19e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—EP300—urinary bladder cancer	4.76e-06	3.12e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—EP300—urinary bladder cancer	4.65e-06	3.04e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—PTEN—urinary bladder cancer	4.59e-06	3.01e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—PTEN—urinary bladder cancer	4.55e-06	2.98e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	4.46e-06	2.92e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—EP300—urinary bladder cancer	4.38e-06	2.87e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PPARG—urinary bladder cancer	4.38e-06	2.86e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—EP300—urinary bladder cancer	4.34e-06	2.84e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	4.21e-06	2.75e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—PTEN—urinary bladder cancer	3.89e-06	2.55e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—EP300—urinary bladder cancer	3.71e-06	2.43e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	3.44e-06	2.25e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—PTEN—urinary bladder cancer	3e-06	1.96e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.86e-06	1.87e-05	CbGpPWpGaD
